Paradigm Biocapital Advisors

Paradigm Biocapital Advisors as of March 31, 2024

Portfolio Holdings for Paradigm Biocapital Advisors

Paradigm Biocapital Advisors holds 34 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvalent Inc-a (NUVL) 11.0 $314M 4.2M 75.09
Arcellx Common Stock (ACLX) 9.3 $266M 3.8M 69.55
Argenx Se Sponsored Adr (ARGX) 7.7 $217M 552k 393.72
Disc Medicine (IRON) 5.2 $149M 2.4M 62.26
Crinetics Pharmaceuticals In (CRNX) 5.1 $146M 3.1M 46.81
Sarepta Therapeutics (SRPT) 4.9 $140M 1.1M 129.46
Immunocore Hldgs Ads (IMCR) 4.1 $116M 1.8M 65.00
Legend Biotech Corp Sponsored Ads (LEGN) 3.9 $111M 2.0M 56.09
Arvinas Ord (ARVN) 3.8 $108M 2.6M 41.28
Xenon Pharmaceuticals (XENE) 3.8 $107M 2.5M 43.05
Tarsus Pharmaceuticals (TARS) 3.7 $104M 2.9M 36.35
Cerevel Therapeutics Hldng I (CERE) 3.5 $99M 2.3M 42.27
Revolution Medicines (RVMD) 3.3 $94M 2.9M 32.23
Olema Pharmaceuticals (OLMA) 3.1 $90M 7.9M 11.32
Miragen Therapeutics (VRDN) 3.1 $88M 5.0M 17.51
Vaxcyte (PCVX) 3.0 $85M 1.2M 68.31
Alpine Immune Sciences 3.0 $84M 2.1M 39.64
Bicycle Therapeutics Sponsored Ads (BCYC) 2.8 $81M 3.2M 24.90
Ascendis Pharma A/s Sponsored Adr (ASND) 2.7 $77M 508k 151.17
Kura Oncology (KURA) 2.4 $67M 3.1M 21.33
Edgewise Therapeutics (EWTX) 1.6 $45M 2.4M 18.24
Autolus Therapeutics Spon Ads (AUTL) 1.4 $41M 6.4M 6.38
Y Mabs Therapeutics 1.3 $36M 2.2M 16.26
Immatics SHS (IMTX) 1.0 $30M 2.8M 10.51
Immunovant (IMVT) 0.9 $26M 799k 32.31
Cullinan Oncology (CGEM) 0.8 $23M 1.3M 17.04
Apogee Therapeutics (APGE) 0.8 $22M 330k 66.45
Compass Pathways Sponsored Ads (CMPS) 0.7 $20M 2.4M 8.32
Vor Biopharma (VOR) 0.5 $15M 6.5M 2.37
Zentalis Pharmaceuticals (ZNTL) 0.5 $15M 945k 15.76
Agios Pharmaceuticals (AGIO) 0.4 $12M 400k 29.24
Caribou Biosciences (CRBU) 0.4 $11M 2.2M 5.14
Cargo Therapeutics (CRGX) 0.1 $3.3M 148k 22.32
Kyverna Therapeutics (KYTX) 0.0 $1.2M 50k 24.84